Western blotting showed that the expression of ACSL4 and TFR1 was lower and that of GPX4 and SLC7A11 was higher in MSC-EV-treated mice with AAA than in control mice (Fig. 5f). The gene discussed is ACSL4; the disease is triple-A syndrome.